Sign in

SS&C Technologies Holdings, Inc. SSNC

Price 83.7 USD
as of 2026-09-05
51/100
Weak
Quality55
Growth56
Balance-sheet strength34
Valuation54
Momentum58
Income50

Composite 51/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 34/100 — a moderate mark against it.

Case for

Momentum ranks 58/100 — a slight point in its favour. Growth ranks 56/100 — a slight point in its favour. Quality ranks 55/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 34/100 — a moderate mark against it.

What the company does SS&C Technologies provides software and software-enabled services to financial services and healthcare industries, covering securities accounting, trading, portfolio management, reconciliation, claims adjudication, and healthcare administration.

Key financials SSNC reports gross margins of 48.1%, operating margins of 24.6%, and net margins of 13.2%. Revenue grew 10.3% and EPS grew 34.7%. ROE is 12.6%, ROA is 4.9%, and ROCE is 9.9%. Debt/Equity is 1.16 with net debt/EBITDA at 3.46.

Stock health The stock is down -8.22% over 6 months and -8.23% over 12 months, trading -14.09% below its 52-week high. RSI(14) is 69.70, indicating elevated momentum.

Price vs fair value SSNC trades at a PREMIUM of 21.70% versus our fair-value estimate of 60.44. - Record Q2 results and raised guidance (Simply Wall St.) - Strong license renewals and AI-driven growth highlighted (StockStory) - Analyst 12-month target implies a discount of 19.65% to 92.33 (analyst count 9.0) - Valuation percentile of 65.6 suggests attractive relative pricing

Looking forward Forward P/E is 10.86 with a PEG of 0.11, suggesting potential earnings growth is undervalued. Recent AI and renewal trends may support sustained revenue and margin expansion.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.